Cardlytics (NASDAQ:CDLX – Get Free Report) will likely be posting its quarterly earnings results after the market closes on Wednesday, March 12th. Analysts expect Cardlytics to post earnings of ($0.24) per share and revenue of $63.63 million for the quarter. Investors interested in registering for the company’s conference call can do so using this link.
Cardlytics Stock Performance
Shares of NASDAQ:CDLX opened at $2.00 on Monday. The company has a market capitalization of $101.64 million, a price-to-earnings ratio of -0.33 and a beta of 1.62. The firm’s 50 day simple moving average is $3.16 and its 200 day simple moving average is $3.55. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18. Cardlytics has a fifty-two week low of $1.99 and a fifty-two week high of $20.52.
Analyst Ratings Changes
Separately, Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a report on Friday, January 17th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Cardlytics presently has a consensus rating of “Hold” and an average price target of $6.92.
Insider Transactions at Cardlytics
In related news, CEO Amit Gupta sold 15,160 shares of Cardlytics stock in a transaction that occurred on Friday, January 24th. The stock was sold at an average price of $3.92, for a total transaction of $59,427.20. Following the sale, the chief executive officer now directly owns 215,494 shares in the company, valued at $844,736.48. The trade was a 6.57 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Alexis Desieno sold 24,778 shares of Cardlytics stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total value of $84,245.20. Following the sale, the chief financial officer now owns 140,948 shares in the company, valued at $479,223.20. This represents a 14.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 111,454 shares of company stock worth $391,864. 4.40% of the stock is owned by company insiders.
Cardlytics Company Profile
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
Featured Stories
- Five stocks we like better than Cardlytics
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- Manufacturing Stocks Investing
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- 3 Tickers Leading a Meme Stock Revival
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.